tert-Butyl 4-benzoylpiperidine-1-carboxylate
CAS: 193217-39-9
Ref. 3D-THA21739
| 1g | A consultar | ||
| 5g | A consultar | ||
| 10g | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Información del producto
Tert-butyl 4-benzoylpiperidine-1-carboxylate (TBCPC) is a novel amide antagonist that has been shown to inhibit HIV entry into cells. TBCPC has been shown to have an oral bioavailability of 100% and a half-life of 10 hours in rats. This compound also had no effect on the pharmacokinetic profile of other drugs, which could make it a good candidate for replacing other anti-HIV drugs. TBCPC has the potential to be developed as a ccr5 antagonist and may have potential applications in treating diseases such as cancer, inflammatory bowel disease, and AIDS.
Propiedades químicas
Consulta técnica sobre: 3D-THA21739 tert-Butyl 4-benzoylpiperidine-1-carboxylate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
